Distribution of Anti-ABO Immunoglobulin G Subclass and C1q Antibody in ABO-incompatible Kidney Transplantation

To investigate the correlation between serum anti-ABO immunoglobulin G (IgG) and IgG subclasses, anti-ABO IgG subclasses were measured by flow cytometry (FCM) in ABO-incompatible (ABOi) kidney transplant recipients. We also evaluated baseline anti-ABO C1q antibody. Baseline anti-ABO IgG titers were...

Full description

Saved in:
Bibliographic Details
Published inTransplantation proceedings Vol. 50; no. 4; pp. 1063 - 1067
Main Authors Lee, K.H., Won, D.I., Yook, J.-M., Kim, K.Y., Park, S.M., Park, J.H., Lee, E.S., Lim, J.-H., Jung, H.-Y., Choi, J.-Y., Park, S.-H., Kim, C.-D., Kim, Y.-L., Kim, H.-K., Huh, S., Cho, J.-H.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.05.2018
Online AccessGet full text

Cover

Abstract To investigate the correlation between serum anti-ABO immunoglobulin G (IgG) and IgG subclasses, anti-ABO IgG subclasses were measured by flow cytometry (FCM) in ABO-incompatible (ABOi) kidney transplant recipients. We also evaluated baseline anti-ABO C1q antibody. Baseline anti-ABO IgG titers were measured by both FCM and column agglutination technique methods in 18 ABOi kidney transplant recipients. The mean florescence intensity (MFI) ratios of baseline anti-ABO IgG subclasses and anti-ABO C1q antibody were obtained by FCM and followed-up after rituximab treatment, each plasmapheresis (PP) session, and kidney transplantation. Correlation between the values of IgG subclass and total IgG titer was analyzed. The baseline MFI ratios of total IgG, IgG1, IgG2, IgG3, and IgG4 were 202.46, 62.41, 30.01, 1.04, and 1.13, respectively. The MFI ratios of IgG1, IgG2, and total IgG measured at baseline and pre-PP were positively correlated with the baseline ABO titer was measured using the column agglutination technique. The numbers of PP sessions to reach the target titer were correlated with the baseline IgG and IgG1 levels. IgG1 and IgG2 as well as total IgG were removed effectively after serial PP. Anti-ABO C1q antibody was neither detected nor correlated with total IgG and any IgG subclasses. Our findings suggest that IgG1 and IgG2 are the dominant IgG subclass in ABOi kidney transplant recipients. Baseline levels of IgG1 and IgG2 were correlated with baseline total IgG titer. However, anti-ABO C1q antibody was not detected in the present study.
AbstractList INTRODUCTIONTo investigate the correlation between serum anti-ABO immunoglobulin G (IgG) and IgG subclasses, anti-ABO IgG subclasses were measured by flow cytometry (FCM) in ABO-incompatible (ABOi) kidney transplant recipients. We also evaluated baseline anti-ABO C1q antibody.METHODBaseline anti-ABO IgG titers were measured by both FCM and column agglutination technique methods in 18 ABOi kidney transplant recipients. The mean florescence intensity (MFI) ratios of baseline anti-ABO IgG subclasses and anti-ABO C1q antibody were obtained by FCM and followed-up after rituximab treatment, each plasmapheresis (PP) session, and kidney transplantation. Correlation between the values of IgG subclass and total IgG titer was analyzed.RESULTSThe baseline MFI ratios of total IgG, IgG1, IgG2, IgG3, and IgG4 were 202.46, 62.41, 30.01, 1.04, and 1.13, respectively. The MFI ratios of IgG1, IgG2, and total IgG measured at baseline and pre-PP were positively correlated with the baseline ABO titer was measured using the column agglutination technique. The numbers of PP sessions to reach the target titer were correlated with the baseline IgG and IgG1 levels. IgG1 and IgG2 as well as total IgG were removed effectively after serial PP. Anti-ABO C1q antibody was neither detected nor correlated with total IgG and any IgG subclasses.CONCLUSIONSOur findings suggest that IgG1 and IgG2 are the dominant IgG subclass in ABOi kidney transplant recipients. Baseline levels of IgG1 and IgG2 were correlated with baseline total IgG titer. However, anti-ABO C1q antibody was not detected in the present study.
To investigate the correlation between serum anti-ABO immunoglobulin G (IgG) and IgG subclasses, anti-ABO IgG subclasses were measured by flow cytometry (FCM) in ABO-incompatible (ABOi) kidney transplant recipients. We also evaluated baseline anti-ABO C1q antibody. Baseline anti-ABO IgG titers were measured by both FCM and column agglutination technique methods in 18 ABOi kidney transplant recipients. The mean florescence intensity (MFI) ratios of baseline anti-ABO IgG subclasses and anti-ABO C1q antibody were obtained by FCM and followed-up after rituximab treatment, each plasmapheresis (PP) session, and kidney transplantation. Correlation between the values of IgG subclass and total IgG titer was analyzed. The baseline MFI ratios of total IgG, IgG1, IgG2, IgG3, and IgG4 were 202.46, 62.41, 30.01, 1.04, and 1.13, respectively. The MFI ratios of IgG1, IgG2, and total IgG measured at baseline and pre-PP were positively correlated with the baseline ABO titer was measured using the column agglutination technique. The numbers of PP sessions to reach the target titer were correlated with the baseline IgG and IgG1 levels. IgG1 and IgG2 as well as total IgG were removed effectively after serial PP. Anti-ABO C1q antibody was neither detected nor correlated with total IgG and any IgG subclasses. Our findings suggest that IgG1 and IgG2 are the dominant IgG subclass in ABOi kidney transplant recipients. Baseline levels of IgG1 and IgG2 were correlated with baseline total IgG titer. However, anti-ABO C1q antibody was not detected in the present study.
Author Kim, C.-D.
Jung, H.-Y.
Choi, J.-Y.
Kim, H.-K.
Kim, Y.-L.
Cho, J.-H.
Park, S.-H.
Won, D.I.
Lee, K.H.
Kim, K.Y.
Lee, E.S.
Park, J.H.
Park, S.M.
Yook, J.-M.
Lim, J.-H.
Huh, S.
Author_xml – sequence: 1
  givenname: K.H.
  surname: Lee
  fullname: Lee, K.H.
  organization: Division of Nephrology, Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, South Korea
– sequence: 2
  givenname: D.I.
  surname: Won
  fullname: Won, D.I.
  organization: Department of Clinical Pathology, School of Medicine, Kyungpook National University, Daegu, South Korea
– sequence: 3
  givenname: J.-M.
  surname: Yook
  fullname: Yook, J.-M.
  organization: Division of Nephrology, Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, South Korea
– sequence: 4
  givenname: K.Y.
  surname: Kim
  fullname: Kim, K.Y.
  organization: Division of Nephrology, Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, South Korea
– sequence: 5
  givenname: S.M.
  surname: Park
  fullname: Park, S.M.
  organization: Division of Nephrology, Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, South Korea
– sequence: 6
  givenname: J.H.
  surname: Park
  fullname: Park, J.H.
  organization: Division of Nephrology, Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, South Korea
– sequence: 7
  givenname: E.S.
  surname: Lee
  fullname: Lee, E.S.
  organization: Division of Nephrology, Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, South Korea
– sequence: 8
  givenname: J.-H.
  surname: Lim
  fullname: Lim, J.-H.
  organization: Division of Nephrology, Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, South Korea
– sequence: 9
  givenname: H.-Y.
  surname: Jung
  fullname: Jung, H.-Y.
  organization: Division of Nephrology, Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, South Korea
– sequence: 10
  givenname: J.-Y.
  surname: Choi
  fullname: Choi, J.-Y.
  organization: Division of Nephrology, Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, South Korea
– sequence: 11
  givenname: S.-H.
  surname: Park
  fullname: Park, S.-H.
  organization: Division of Nephrology, Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, South Korea
– sequence: 12
  givenname: C.-D.
  surname: Kim
  fullname: Kim, C.-D.
  organization: Division of Nephrology, Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, South Korea
– sequence: 13
  givenname: Y.-L.
  surname: Kim
  fullname: Kim, Y.-L.
  organization: Division of Nephrology, Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, South Korea
– sequence: 14
  givenname: H.-K.
  surname: Kim
  fullname: Kim, H.-K.
  organization: Department of Surgery, School of Medicine, Kyungpook National University, Daegu, South Korea
– sequence: 15
  givenname: S.
  surname: Huh
  fullname: Huh, S.
  organization: Department of Surgery, School of Medicine, Kyungpook National University, Daegu, South Korea
– sequence: 16
  givenname: J.-H.
  surname: Cho
  fullname: Cho, J.-H.
  email: jh-cho@knu.ac.kr
  organization: Division of Nephrology, Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, South Korea
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29731066$$D View this record in MEDLINE/PubMed
BookMark eNqNkEFv3CAQhVGUKtmk-QsV6qkXuwPYhvS23bRp1Eg5NDkjDOOKlQ0bsCvtvy-bTaQeexox89684bsgpyEGJOQjg5oB6z5v6zmZkHcpWkRXc2CqBlZDo07IiikpKt5xcUpWAA2rmGjac3KR8xbKmzfijJzzaykYdN2KhBuf5-T7ZfYx0DjQdZh9tf76QO-maQnx9xj7ZfSB3tJfS29HkzM1wdENe36R9tHtaRkXR-WDjdPOlOaI9Kd3Aff08eXS0YTZHBLek3eDGTNevdZL8vT92-PmR3X_cHu3Wd9XViiYK2E4t3awHTQDV6aXytrWQa8aZ4BJVxoDl0wqlFzCtVDILDStggG5ZawRl-TTcW-B9LxgnvXks8WxHIJxyZqDaGWh0bIi_XKU2hRzTjjoXfKTSXvNQB94663-l7c-8NbAdOFdzB9ec5Z-KrM36xvgIrg5CrD89o_HpLP1GCw6n9DO2kX_Pzl_AVw-mnY
CitedBy_id crossref_primary_10_1111_trf_15726
crossref_primary_10_1371_journal_pone_0222537
crossref_primary_10_1111_vox_13260
crossref_primary_10_1016_j_trim_2021_101484
Cites_doi 10.1182/blood-2007-04-082719
10.1053/tmrv.2002.33460
10.1681/ASN.2013101144
10.1097/01.tp.0000296018.82857.ef
10.1111/tri.12000
10.1111/j.1600-6143.2008.02538.x
10.1097/TP.0b013e318245b2af
10.1016/j.transproceed.2014.11.046
10.1056/NEJMoa1302506
10.1182/blood-2012-02-407452
10.1034/j.1600-6143.2003.00179.x
10.1016/j.trre.2012.07.003
10.1097/TP.0b013e31820f08e8
10.1111/j.1600-6143.2006.01676.x
10.1097/MOT.0b013e32833b9cb7
10.1097/TP.0000000000000699
10.3389/fimmu.2016.00433
10.1309/LM1O8F7MLLYIPIMZ
10.1111/j.1600-6143.2010.03103.x
10.1097/TP.0b013e31821cdf0d
10.1016/j.molimm.2007.06.158
10.1016/j.krcp.2015.08.005
ContentType Journal Article
Copyright 2018 Elsevier Inc.
Copyright © 2018 Elsevier Inc. All rights reserved.
Copyright_xml – notice: 2018 Elsevier Inc.
– notice: Copyright © 2018 Elsevier Inc. All rights reserved.
DBID NPM
AAYXX
CITATION
7X8
DOI 10.1016/j.transproceed.2018.01.048
DatabaseName PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle PubMed
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Biology
Pharmacy, Therapeutics, & Pharmacology
EISSN 1873-2623
EndPage 1067
ExternalDocumentID 10_1016_j_transproceed_2018_01_048
29731066
S0041134518301192
Genre Journal Article
GroupedDBID ---
--K
--M
.1-
.55
.FO
.GJ
.~1
0R~
123
1B1
1P~
1~.
1~5
29Q
3O-
4.4
457
4G.
53G
5RE
5VS
7-5
71M
8P~
AABNK
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AAXUO
ABBQC
ABFRF
ABJNI
ABLJU
ABLVK
ABMAC
ABMZM
ABOCM
ABXDB
ABYKQ
ACDAQ
ACGFO
ACIUM
ACRLP
ADBBV
ADEZE
ADMUD
AEBSH
AEFWE
AEKER
AENEX
AEVXI
AFCTW
AFKWA
AFRHN
AFTJW
AFXIZ
AGHFR
AGUBO
AGYEJ
AHPSJ
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
AJRQY
AJUYK
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CS3
DU5
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-Q
GBLVA
HVGLF
HZ~
IHE
J1W
J5H
K-O
KOM
L7B
LCYCR
M41
MO0
N9A
O-L
O9-
OAUVE
OK-
OW-
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SCC
SDF
SDG
SDP
SEL
SES
SEW
SPCBC
SSH
SSZ
T5K
UDS
WH7
X7M
XPP
Y6R
Z5R
ZA5
ZGI
ZXP
~G-
AAXKI
AFJKZ
AKRWK
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c380t-3a22ccfc604f28ab78cc5d0b84da017db78f27178e7270938e1c04580fe2c1143
IEDL.DBID AIKHN
ISSN 0041-1345
IngestDate Fri Aug 16 01:54:52 EDT 2024
Thu Sep 26 18:57:14 EDT 2024
Wed Oct 16 00:57:23 EDT 2024
Fri Feb 23 02:27:24 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 4
Language English
License Copyright © 2018 Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c380t-3a22ccfc604f28ab78cc5d0b84da017db78f27178e7270938e1c04580fe2c1143
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Undefined-1
ObjectType-Feature-3
content type line 23
PMID 29731066
PQID 2035704251
PQPubID 23479
PageCount 5
ParticipantIDs proquest_miscellaneous_2035704251
crossref_primary_10_1016_j_transproceed_2018_01_048
pubmed_primary_29731066
elsevier_sciencedirect_doi_10_1016_j_transproceed_2018_01_048
PublicationCentury 2000
PublicationDate May 2018
2018-May
2018-05-00
20180501
PublicationDateYYYYMMDD 2018-05-01
PublicationDate_xml – month: 05
  year: 2018
  text: May 2018
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Transplantation proceedings
PublicationTitleAlternate Transplant Proc
PublicationYear 2018
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Tobian, Shirey, Montgomery, Cai, Haas, Ness (bib3) 2010; 10
Koo, Yang (bib10) 2015; 34
Takahashi, Saito (bib4) 2013; 27
Irei, Ohdan, Zhou, Ishiyama, Tanaka, Ide (bib11) 2007; 110
Cicciarelli, Lemp, Chang, Koss, Hacke, Kasahara (bib23) 2017; 2017
Elham, Wuding, Steven (bib17) 2010; 15
Bartel, Wahrmann, Schwaiger, Kikić, Winzer, Hörl (bib22) 2013; 26
Toki, Ishida, Setoguchi, Shimizu, Omoto, Shirakawa (bib13) 2009; 9
Valenzuela, Hickey, Reed (bib15) 2016; 7
Kim, Jung, Choi, Cho, Park, Kim (bib8) 2015; 47
Yell, Muth, Kaufman, Djamali, Ellis (bib20) 2015; 99
Montgomery, Berger, Warren, James, Montgomery, Segev (bib1) 2012; 93
Ishida, Miyamoto, Shirakawa, Shimizu, Tokumoto, Ishikawa (bib6) 2007; 7
Tazawa, Irei, Tanaka, Igarashi, Tashiro, Ohdan (bib12) 2013; 122
Bos, Ten Berge, Hack (bib18) 2002; 16
Sicard, Ducreux, Rabeyrin, Couzi, McGregor, Badet (bib21) 2015; 26
Fuchinoue, Ishii, Sawada, Murakami, Iwadoh, Sannomiya (bib5) 2011; 91
Loupy, Lefaucheur, Vernerey, Prugger, van Huyen, Mooney (bib19) 2013; 369
Won, Kim (bib9) 2012; 43
Hönger, Hopfer, Arnold, Spriewald, Schaub, Amico (bib14) 2011; 92
Park, Grande, Ninova, Nath, Platt, Gloor (bib2) 2003; 3
Lewis, Wagner, Woof (bib16) 2008; 45
Tanabe (bib7) 2007; 84
Park (10.1016/j.transproceed.2018.01.048_bib2) 2003; 3
Tazawa (10.1016/j.transproceed.2018.01.048_bib12) 2013; 122
Toki (10.1016/j.transproceed.2018.01.048_bib13) 2009; 9
Tobian (10.1016/j.transproceed.2018.01.048_bib3) 2010; 10
Cicciarelli (10.1016/j.transproceed.2018.01.048_bib23) 2017; 2017
Fuchinoue (10.1016/j.transproceed.2018.01.048_bib5) 2011; 91
Irei (10.1016/j.transproceed.2018.01.048_bib11) 2007; 110
Valenzuela (10.1016/j.transproceed.2018.01.048_bib15) 2016; 7
Ishida (10.1016/j.transproceed.2018.01.048_bib6) 2007; 7
Kim (10.1016/j.transproceed.2018.01.048_bib8) 2015; 47
Elham (10.1016/j.transproceed.2018.01.048_bib17) 2010; 15
Sicard (10.1016/j.transproceed.2018.01.048_bib21) 2015; 26
Takahashi (10.1016/j.transproceed.2018.01.048_bib4) 2013; 27
Montgomery (10.1016/j.transproceed.2018.01.048_bib1) 2012; 93
Tanabe (10.1016/j.transproceed.2018.01.048_bib7) 2007; 84
Hönger (10.1016/j.transproceed.2018.01.048_bib14) 2011; 92
Bos (10.1016/j.transproceed.2018.01.048_bib18) 2002; 16
Won (10.1016/j.transproceed.2018.01.048_bib9) 2012; 43
Loupy (10.1016/j.transproceed.2018.01.048_bib19) 2013; 369
Bartel (10.1016/j.transproceed.2018.01.048_bib22) 2013; 26
Koo (10.1016/j.transproceed.2018.01.048_bib10) 2015; 34
Lewis (10.1016/j.transproceed.2018.01.048_bib16) 2008; 45
Yell (10.1016/j.transproceed.2018.01.048_bib20) 2015; 99
References_xml – volume: 122
  start-page: 2582
  year: 2013
  end-page: 2590
  ident: bib12
  article-title: Blockade of invariant TCR-CD1d interaction specifically inhibits antibody production against blood group A carbohydrates
  publication-title: Blood
  contributor:
    fullname: Ohdan
– volume: 15
  start-page: 486
  year: 2010
  ident: bib17
  article-title: Complement in organ transplantation
  publication-title: Curr Opin Organ Transplant
  contributor:
    fullname: Steven
– volume: 45
  start-page: 818
  year: 2008
  end-page: 827
  ident: bib16
  article-title: The different effector function capabilities of the seven equine IgG subclasses have implications for vaccine strategies
  publication-title: Mol Immunol
  contributor:
    fullname: Woof
– volume: 7
  start-page: 825
  year: 2007
  end-page: 831
  ident: bib6
  article-title: Evaluation of immunosuppressive regimens in ABO-incompatible living kidney transplantation — single center analysis
  publication-title: Am J Transplant
  contributor:
    fullname: Ishikawa
– volume: 34
  start-page: 170
  year: 2015
  end-page: 179
  ident: bib10
  article-title: Current progress in ABO-incompatible kidney transplantation
  publication-title: Kidney Res Clin Pract
  contributor:
    fullname: Yang
– volume: 7
  start-page: 433
  year: 2016
  ident: bib15
  article-title: Antibody subclass repertoire and graft outcome following solid organ transplantation
  publication-title: Front Immunol
  contributor:
    fullname: Reed
– volume: 9
  start-page: 567
  year: 2009
  end-page: 577
  ident: bib13
  article-title: Acute antibody-mediated rejection in living ABO-incompatible kidney transplantation: long-term impact and risk factors
  publication-title: Am J Transplant
  contributor:
    fullname: Shirakawa
– volume: 26
  start-page: 121
  year: 2013
  end-page: 130
  ident: bib22
  article-title: Solid phase detection of C4d-fixing HLA antibodies to predict rejection in high immunological risk kidney transplant recipients
  publication-title: Transplant Int
  contributor:
    fullname: Hörl
– volume: 91
  start-page: 853
  year: 2011
  end-page: 857
  ident: bib5
  article-title: The 5-year outcome of ABO-incompatible kidney transplantation with rituximab induction
  publication-title: Transplantation
  contributor:
    fullname: Sannomiya
– volume: 92
  start-page: 41
  year: 2011
  end-page: 47
  ident: bib14
  article-title: Pretransplant IgG subclasses of donor-specific human leukocyte antigen antibodies and development of antibody-mediated rejection
  publication-title: Transplantation
  contributor:
    fullname: Amico
– volume: 27
  start-page: 1
  year: 2013
  end-page: 8
  ident: bib4
  article-title: ABO-incompatible kidney transplantation
  publication-title: Transplant Rev
  contributor:
    fullname: Saito
– volume: 3
  start-page: 952
  year: 2003
  end-page: 960
  ident: bib2
  article-title: Accommodation in ABO-incompatible kidney allografts, a novel mechanism of self-protection against antibody-mediated injury
  publication-title: Am J Transplant
  contributor:
    fullname: Gloor
– volume: 369
  start-page: 1215
  year: 2013
  end-page: 1226
  ident: bib19
  article-title: Complement-binding anti-HLA antibodies and kidney-allograft survival
  publication-title: N Engl J Med
  contributor:
    fullname: Mooney
– volume: 2017
  start-page: 1652931
  year: 2017
  ident: bib23
  article-title: Renal transplant patients biopsied for cause and tested for C4d, DSA, and IgG subclasses and C1q: which humoral markers improve diagnosis and outcomes?
  publication-title: J Immunol Res
  contributor:
    fullname: Kasahara
– volume: 10
  start-page: 1247
  year: 2010
  end-page: 1253
  ident: bib3
  article-title: ABO antibody titer and risk of antibody-mediated rejection in abo-incompatible renal transplantation
  publication-title: Am J Transplant
  contributor:
    fullname: Ness
– volume: 93
  start-page: 603
  year: 2012
  ident: bib1
  article-title: Outcomes of ABO-incompatible kidney transplantation in the United States
  publication-title: Transplantation
  contributor:
    fullname: Segev
– volume: 26
  start-page: 457
  year: 2015
  end-page: 467
  ident: bib21
  article-title: Detection of C3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss
  publication-title: J Am Soc Nephrol
  contributor:
    fullname: Badet
– volume: 47
  start-page: 591
  year: 2015
  end-page: 595
  ident: bib8
  article-title: Application of flow cytometry to measure anti-A/B antibody in ABO-incompatible kidney transplantation
  publication-title: Transplant Proc
  contributor:
    fullname: Kim
– volume: 110
  start-page: 4567
  year: 2007
  end-page: 4575
  ident: bib11
  article-title: The persistent elimination of B cells responding to blood group A carbohydrates by synthetic group A carbohydrates and B-1 cell differentiation blockade: novel concept in preventing antibody-mediated rejection in ABO-incompatible transplantation
  publication-title: Blood
  contributor:
    fullname: Ide
– volume: 84
  start-page: S13
  year: 2007
  end-page: S16
  ident: bib7
  article-title: Interinstitutional variation in the measurement of anti-A/B antibodies: the Japanese ABO-Incompatible Transplantation Committee survey
  publication-title: Transplantation
  contributor:
    fullname: Tanabe
– volume: 99
  start-page: 1151
  year: 2015
  end-page: 1155
  ident: bib20
  article-title: C1q binding activity of de novo donor-specific HLA antibodies in renal transplant recipients with and without antibody-mediated rejection
  publication-title: Transplantation
  contributor:
    fullname: Ellis
– volume: 43
  start-page: 281
  year: 2012
  end-page: 290
  ident: bib9
  article-title: Optimized flow cytometry to measure anti-ABO immunoglobulin G
  publication-title: Lab Med
  contributor:
    fullname: Kim
– volume: 16
  start-page: 251
  year: 2002
  end-page: 264
  ident: bib18
  article-title: Role of complement in graft rejection after organ transplantation
  publication-title: Transfus Med Rev
  contributor:
    fullname: Hack
– volume: 110
  start-page: 4567
  issue: 13
  year: 2007
  ident: 10.1016/j.transproceed.2018.01.048_bib11
  article-title: The persistent elimination of B cells responding to blood group A carbohydrates by synthetic group A carbohydrates and B-1 cell differentiation blockade: novel concept in preventing antibody-mediated rejection in ABO-incompatible transplantation
  publication-title: Blood
  doi: 10.1182/blood-2007-04-082719
  contributor:
    fullname: Irei
– volume: 16
  start-page: 251
  issue: 3
  year: 2002
  ident: 10.1016/j.transproceed.2018.01.048_bib18
  article-title: Role of complement in graft rejection after organ transplantation
  publication-title: Transfus Med Rev
  doi: 10.1053/tmrv.2002.33460
  contributor:
    fullname: Bos
– volume: 26
  start-page: 457
  year: 2015
  ident: 10.1016/j.transproceed.2018.01.048_bib21
  article-title: Detection of C3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.2013101144
  contributor:
    fullname: Sicard
– volume: 84
  start-page: S13
  issue: 12S
  year: 2007
  ident: 10.1016/j.transproceed.2018.01.048_bib7
  article-title: Interinstitutional variation in the measurement of anti-A/B antibodies: the Japanese ABO-Incompatible Transplantation Committee survey
  publication-title: Transplantation
  doi: 10.1097/01.tp.0000296018.82857.ef
  contributor:
    fullname: Tanabe
– volume: 26
  start-page: 121
  issue: 2
  year: 2013
  ident: 10.1016/j.transproceed.2018.01.048_bib22
  article-title: Solid phase detection of C4d-fixing HLA antibodies to predict rejection in high immunological risk kidney transplant recipients
  publication-title: Transplant Int
  doi: 10.1111/tri.12000
  contributor:
    fullname: Bartel
– volume: 9
  start-page: 567
  issue: 3
  year: 2009
  ident: 10.1016/j.transproceed.2018.01.048_bib13
  article-title: Acute antibody-mediated rejection in living ABO-incompatible kidney transplantation: long-term impact and risk factors
  publication-title: Am J Transplant
  doi: 10.1111/j.1600-6143.2008.02538.x
  contributor:
    fullname: Toki
– volume: 2017
  start-page: 1652931
  year: 2017
  ident: 10.1016/j.transproceed.2018.01.048_bib23
  article-title: Renal transplant patients biopsied for cause and tested for C4d, DSA, and IgG subclasses and C1q: which humoral markers improve diagnosis and outcomes?
  publication-title: J Immunol Res
  contributor:
    fullname: Cicciarelli
– volume: 93
  start-page: 603
  issue: 6
  year: 2012
  ident: 10.1016/j.transproceed.2018.01.048_bib1
  article-title: Outcomes of ABO-incompatible kidney transplantation in the United States
  publication-title: Transplantation
  doi: 10.1097/TP.0b013e318245b2af
  contributor:
    fullname: Montgomery
– volume: 47
  start-page: 591
  year: 2015
  ident: 10.1016/j.transproceed.2018.01.048_bib8
  article-title: Application of flow cytometry to measure anti-A/B antibody in ABO-incompatible kidney transplantation
  publication-title: Transplant Proc
  doi: 10.1016/j.transproceed.2014.11.046
  contributor:
    fullname: Kim
– volume: 369
  start-page: 1215
  issue: 13
  year: 2013
  ident: 10.1016/j.transproceed.2018.01.048_bib19
  article-title: Complement-binding anti-HLA antibodies and kidney-allograft survival
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1302506
  contributor:
    fullname: Loupy
– volume: 122
  start-page: 2582
  issue: 15
  year: 2013
  ident: 10.1016/j.transproceed.2018.01.048_bib12
  article-title: Blockade of invariant TCR-CD1d interaction specifically inhibits antibody production against blood group A carbohydrates
  publication-title: Blood
  doi: 10.1182/blood-2012-02-407452
  contributor:
    fullname: Tazawa
– volume: 3
  start-page: 952
  issue: 8
  year: 2003
  ident: 10.1016/j.transproceed.2018.01.048_bib2
  article-title: Accommodation in ABO-incompatible kidney allografts, a novel mechanism of self-protection against antibody-mediated injury
  publication-title: Am J Transplant
  doi: 10.1034/j.1600-6143.2003.00179.x
  contributor:
    fullname: Park
– volume: 27
  start-page: 1
  issue: 1
  year: 2013
  ident: 10.1016/j.transproceed.2018.01.048_bib4
  article-title: ABO-incompatible kidney transplantation
  publication-title: Transplant Rev
  doi: 10.1016/j.trre.2012.07.003
  contributor:
    fullname: Takahashi
– volume: 91
  start-page: 853
  issue: 8
  year: 2011
  ident: 10.1016/j.transproceed.2018.01.048_bib5
  article-title: The 5-year outcome of ABO-incompatible kidney transplantation with rituximab induction
  publication-title: Transplantation
  doi: 10.1097/TP.0b013e31820f08e8
  contributor:
    fullname: Fuchinoue
– volume: 7
  start-page: 825
  issue: 4
  year: 2007
  ident: 10.1016/j.transproceed.2018.01.048_bib6
  article-title: Evaluation of immunosuppressive regimens in ABO-incompatible living kidney transplantation — single center analysis
  publication-title: Am J Transplant
  doi: 10.1111/j.1600-6143.2006.01676.x
  contributor:
    fullname: Ishida
– volume: 15
  start-page: 486
  issue: 4
  year: 2010
  ident: 10.1016/j.transproceed.2018.01.048_bib17
  article-title: Complement in organ transplantation
  publication-title: Curr Opin Organ Transplant
  doi: 10.1097/MOT.0b013e32833b9cb7
  contributor:
    fullname: Elham
– volume: 99
  start-page: 1151
  issue: 6
  year: 2015
  ident: 10.1016/j.transproceed.2018.01.048_bib20
  article-title: C1q binding activity of de novo donor-specific HLA antibodies in renal transplant recipients with and without antibody-mediated rejection
  publication-title: Transplantation
  doi: 10.1097/TP.0000000000000699
  contributor:
    fullname: Yell
– volume: 7
  start-page: 433
  year: 2016
  ident: 10.1016/j.transproceed.2018.01.048_bib15
  article-title: Antibody subclass repertoire and graft outcome following solid organ transplantation
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2016.00433
  contributor:
    fullname: Valenzuela
– volume: 43
  start-page: 281
  issue: 6
  year: 2012
  ident: 10.1016/j.transproceed.2018.01.048_bib9
  article-title: Optimized flow cytometry to measure anti-ABO immunoglobulin G
  publication-title: Lab Med
  doi: 10.1309/LM1O8F7MLLYIPIMZ
  contributor:
    fullname: Won
– volume: 10
  start-page: 1247
  issue: 5
  year: 2010
  ident: 10.1016/j.transproceed.2018.01.048_bib3
  article-title: ABO antibody titer and risk of antibody-mediated rejection in abo-incompatible renal transplantation
  publication-title: Am J Transplant
  doi: 10.1111/j.1600-6143.2010.03103.x
  contributor:
    fullname: Tobian
– volume: 92
  start-page: 41
  issue: 1
  year: 2011
  ident: 10.1016/j.transproceed.2018.01.048_bib14
  article-title: Pretransplant IgG subclasses of donor-specific human leukocyte antigen antibodies and development of antibody-mediated rejection
  publication-title: Transplantation
  doi: 10.1097/TP.0b013e31821cdf0d
  contributor:
    fullname: Hönger
– volume: 45
  start-page: 818
  issue: 3
  year: 2008
  ident: 10.1016/j.transproceed.2018.01.048_bib16
  article-title: The different effector function capabilities of the seven equine IgG subclasses have implications for vaccine strategies
  publication-title: Mol Immunol
  doi: 10.1016/j.molimm.2007.06.158
  contributor:
    fullname: Lewis
– volume: 34
  start-page: 170
  issue: 3
  year: 2015
  ident: 10.1016/j.transproceed.2018.01.048_bib10
  article-title: Current progress in ABO-incompatible kidney transplantation
  publication-title: Kidney Res Clin Pract
  doi: 10.1016/j.krcp.2015.08.005
  contributor:
    fullname: Koo
SSID ssj0004243
Score 2.2655714
Snippet To investigate the correlation between serum anti-ABO immunoglobulin G (IgG) and IgG subclasses, anti-ABO IgG subclasses were measured by flow cytometry (FCM)...
INTRODUCTIONTo investigate the correlation between serum anti-ABO immunoglobulin G (IgG) and IgG subclasses, anti-ABO IgG subclasses were measured by flow...
SourceID proquest
crossref
pubmed
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 1063
Title Distribution of Anti-ABO Immunoglobulin G Subclass and C1q Antibody in ABO-incompatible Kidney Transplantation
URI https://dx.doi.org/10.1016/j.transproceed.2018.01.048
https://www.ncbi.nlm.nih.gov/pubmed/29731066
https://search.proquest.com/docview/2035704251
Volume 50
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELbKVkhcELQ8tkBlJNRTTePY2XgPHNKFsqVS4dBKvVnxI9JWrVNoesilv50ZO2lBAgmJW-zYipWx52F_85mQd8aWjhspmQTfgoHFc8wUwjMHZc59iXsfiLY4ni1P5Zez4myNLMZcGIRVDro_6fSorYeaveFv7l2tVpjjKzkXsoBJicRloIfXwRxJOSHr1eHR8vg-PTIfwXOcYYeRezTCvLrIIZ6MBSK9VGTxxOuA_myn_uaHRnt08IQ8HhxJWqWxPiVrPmyQzSpAEH3Z0x0aoZ1xz3yDPNwfn3a-Jarqfpee3GdeXe_GDnck1v0mCR-RUXe4DIu2Da1Ct2LV_ld6iBklLRKJIIidfqageyz64LQOji7499jUtK6n8Bp6MCSAuETktrnw9Gjlgu9pIlW_qFPmU3hGTg8-nSyWbLibgVmhso6JOs-tbewsk02ualMqawuXGSVdDYvcQUWTQ6ioPDhI2Vwozy2eyWaNzy3EYOI5mYQ2-JeEls7PVW6Mm7lc1plTc2UycEsbWwuMJqdEjJLQV4mCQ4_YtHP9q_w0yk9nXIP8puTDKDT924TSYCv-qf_bUdIaVhweo9TBtzfX0EgUJeo6PiUv0hS4G1e8CQy8uK3__Por8ghLCVn5mky6Hzf-DXg_ndkmD97f8u1hjv8EHkEFLA
link.rule.ids 315,786,790,4521,24144,27955,27956,45618,45712
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Nb9QwELWqIgQXRFugC7QYCfVU0zh2Nt4Dh-2WsqWlcNhKvVnxR6RFrVNoesiF386MnbQggYTELR-2YmWcmTfOm2dC3hhbOm6kZBKwBYOI55gphGcOzjn3Ja59INvidDw_kx_Pi_MVMhtqYZBW2fv-5NOjt-6v7PVvc-9qucQaX8m5kAVMShQuAz98D9EA8rre_rjjech8oM5xhs0H5dFI8mqjgngKFcjzUlHDEzcD-nOU-hsKjdHo8DF51MNIOk0jXSMrPqyTjWmAFPqyozs0Ejvjivk6ub8_HO18SULV3S5d3NVdXe_GDrcS1t0GCQeop9tvhUWbmk5Du2TT_c_0COtJGpQRQQo7_UDB81hE4LQKjs74t9jUNK6jcBt6MJR_uETetrnw9Hjpgu9oklS_qFLdU3hCzg7fL2Zz1u_MwKxQWctElefW1nacyTpXlSmVtYXLjJKugk_cwYU6h0RReYBH2UQozy3-kc1qn1vIwMRTshqa4DcJLZ2fqNwYN3a5rDKnJspkAEprWwnMJUdEDJbQV0mAQw_MtK_6V_tptJ_OuAb7jci7wWj6t-mkIVL8U__Xg6U1fG_4E6UKvrm5hkaiKNHT8RF5lqbA7bjiPmCA4Z7_59NfkQfzxacTfXJ0evyCPMQ7iWP5kqy232_8FuCg1mzHef4Tdm8GAQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Distribution+of+Anti-ABO+Immunoglobulin+G+Subclass+and+C1q+Antibody+in+ABO-incompatible+Kidney+Transplantation&rft.jtitle=Transplantation+proceedings&rft.au=Lee%2C+K.H.&rft.au=Won%2C+D.I.&rft.au=Yook%2C+J.-M.&rft.au=Kim%2C+K.Y.&rft.date=2018-05-01&rft.issn=0041-1345&rft.volume=50&rft.issue=4&rft.spage=1063&rft.epage=1067&rft_id=info:doi/10.1016%2Fj.transproceed.2018.01.048&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_transproceed_2018_01_048
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0041-1345&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0041-1345&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0041-1345&client=summon